The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry in less than a ten-year period.
Within the United States, cord blood banks have appeared in nearly every state. Furthermore, the U.S. cord blood banking industry is the most mature cord blood banking market in the world, having the:
- First company to offer cord blood storage (1995)
- Early entrant into cord tissue storage (2010)
- Largest total number of industry participants (both public and private)
- Most number of cord blood units (CBU) stored
- Most cord blood units banked proportional to population
- This rapid market growth represents both an opportunity to profit, as well as swarming competition.
- A Fast-Growth Industry, Driven by Medical Necessity and Consumer Demand
The field of cord blood banking is a fast-growth field, driven by medical necessity and consumer demand. It is also a recent industry, as it was not until 1974 that it was first proposed that stem and progenitor cells were present in human cord blood and 1983 that umbilical cord blood was proposed as an alternative source of stem cells for transplant. In 1988, the first successful cord blood transplant occurred, but it was not until 1995 that the first private cord blood bank began operations.
Furthermore, it was not until July, 2010, when the Cord Blood Registry became the first private U.S. cord blood bank to offer umbilical cord tissue storage. In the two years that have since passed then, the number of private U.S. cord blood banks offering cord tissue storage has risen to nine. This represents an average of one new U.S. cord blood bank adding cord tissue storage every 3 months. If this rate continues, half of all private U.S. cord blood banks will offer cord tissue storage within two years.
Since the first cord blood transplant was performed in 1988, stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, there is still significant variation within the industry. There is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a wide geographic region.
There is also variation in the services offered by private cord blood banks, as some companies only offer cord blood storage only and others offer it in conjunction with cord tissue storage. Finally, there is also significant variation in the quality, pricing and guarantees promised by cord blood banks.
Report Format and Key Findings
In this comprehensive industry report, you\'ll learn:
Part 1: U.S. Cord Blood Banking Industry Market Overview & Outlook
The first section of the report “roots” where the cord blood banking industry has been, what has shaped it, and where it is going. Using both qualitative and quantitative assessment, it explores critical timeline events, current and future conditions treatable, advantages of cord blood transplant, probabilities of requiring stem cell transplant throughout the lifespan, and more. With this detailed knowledge, you can know the relative strength of your position within the marketplace.
Part 2: Expansion and Growth – Trailing 12-Month Analysis & Forward Projections
The second section explores where the U.S. cord blood banking industry is now and what you should anticipate for the near-term future, based on recent trends and five-year projections. Critically, it explores strategies of fast-growth U.S. companies and compares their actions and attributes to slow-growth companies, providing a comprehensive road-map to industry dominance.
Furthermore, detailed assessment of U.S. cord blood industry trends are presented in this section, including:
- Rates of cord blood storage
- Rates of parental awareness
- Trends in medical opinions of cord blood banking
- Quantitative analysis of cord blood grant funding, publication rates, and patents
And much more
Part 3: Comprehensive Parent Survey Continuing to Grow by Listening to Expectant Parents
While the last section showed you what to expect if trends continue as they are and revealed the environment that you will find yourself in within the next five years, this final section is your guide to taking strategic action and controlling your competitive position.
This section contains findings from a detailed survey that reveals how U.S. parents learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the mind of your prospective clients. Key findings from the survey include how to:
- Strategically position your products
- Understand why expectant parents bank publicly, privately, or not at all
- Communicate successfully with parents
- Effectively educate parents
- Prioritize your advertising budget
- Sell your services more effectively
In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents within the U.S.
Your Roadmap to the Next 5 Years
Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry, as well as revenue growth at existing operations. To guide industry competitors, this report carefully considers the following questions:
- What factors are causing a substantial number of new cord blood banks to open up business?
- What will be the effect of these new entrants to the cord blood banking industry?
- How can existing competitors maintain a position of dominance among this trend?
Deeper analysis also reveals that existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).
While a similar bimodal distribution existed in the prior 12 month period (trailing 12 to 24 months), the peaks have continued to separate over the past 12 months, with the average flat-growth company staying stagnant and the average revenue growth company increasing its per annum growth rate from 17% per year to 25% per year. This trend indicates an increasing shift in dominance toward fast-growth companies, which begs the questions:
- What are the differences among the cord blood banks that are experiencing flat-line growth, versus those that have substantively building revenue?
- Why are the fast-growth companies continuing to increase their dominance relative to the flat growth companies?
- Why Claim the Complete 2013-14
- U.S. Cord Blood Banking Industry Report?
As mentioned above, this industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.
It teaches you management of a private cord blood bank how to strategically position your services to increase market share and attract expectant parents to your company.
Rather than focusing on the “medical” and “technical” aspects of cord blood stem cells, the report focuses on the practical and strategic applications necessary to successfully run a private cord blood bank. While the medical angle is interesting, you already know that part of you business. It would tell you nothing about strategic actions to take to have more expectant parents purchasing services from you, instead of the competition.
Instead, this industry report is focused on your needs and includes content relevant to what you want to know how to optimally price your services, criteria that make expectant parents likely to purchase private cord blood banking services, and how to grow in a competitive industry.
Like it or not, the cord blood banking industry is getting more and more competitive every day. By doing nothing, clients will likely be won over by better informed, or simply more aggressive, competitors.
What You Can Expect
Increase Your Customer Base – Have more parents electing to use your cord blood banking services when you strategically understand your industry.
Become a Strategic Leader – Leverage this valuable, detailed, and rare information to ensure that you are fully equipped with the necessary information to successfully lead you company and achieve desired results.
Increase Profits Make more profit while putting forth less effort than before.
Industry Security – Be able to both survive and thrive in the cord blood banking industry, even as it becomes much more competitive. Can you survive if the quantity of your competition doubles again? It is likely to happen.
Crush Competition – Be able to take away market share from the competition as you gain a strategic “edge”.
Table of Content
PART 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook
I. Timeline of Critical Events in U.S. Cord Blood Banking
II. Likelihood of Needing a Stem Cell Transplant
A. Childhood Probability
B. Adult Probability
C. Full Life-Span Analysis
III. Current, Near-Term, and Projected Conditions Treatable with Cord Blood Transplant
A. Categories of Disease Treatable With Cord Blood Transplant
B. Existing Conditions
C. Near-Term Conditions
1. Human Trials
2. Laboratory Trials
D. Projected Conditions
IV. Cord Blood vs. Bone Marrow and Peripheral Blood, as a Source of Stem Cells for Transplant
V. Cord Blood Banking – Storage Options
A. Private Banks
B. Public Banks
1. Free Programs for U.S. Families in Medical Need
2. U.S. Mail-in Donation (Public) Cord Blood Banks
C. International Summary and Comparison
PART 2: Expansion and Growth – Trailing Twelve Month Analysis & Forward Projections
I. Fast-Growth vs. Flat-Growth – Bimodal Distribution
II. Growth Rate
A. Flat-line growth companies (25% per year)
IV. Industry Conditions – North America
B. United States
A. Rates of Worldwide Cord Blood Storage (Units per Year)
B. Rates of Parental Awareness
C. Medical Society Opinions of Cord Blood Banking
D. Cord Blood Research Publication Rates
E. Cord Blood Research Funding Levels (Grant Analysis)
F. Cord Blood Patent Breakdown
G. Rates of Cord Blood Research Product Development
H. Top Countries for Cord Blood Research
I. Cord Blood Conferences & Events
VI. Cord Tissue Storage
A. Overview of Cord Blood Storage vs. Cord Tissue Storage
B. Pricing of Cord Tissue Storage
C. Clinical Trials – Cord Blood vs. Cord Tissue
D. Market Penetration of Cord Tissue Storage
VII. Barriers to Entering the U.S. Cord Blood Market
1. Types of Accreditation
2. AABB Overview
3. ABB Accredited Cord Blood Banks
4. Current Conditions
a. Rise in cGTP and cGMP Compliance Consultancy
b. Single Entity Expansion
B. Security requirements
C. Laboratory and storage requirements
VIII. Leveraging Novel Tactics for Substantive Revenue Growth
A. Strategic Collaborations
1. Regional Hospitals and Birthing Centers
a. Public Banking System
b. Private Banking System
2. Broad-Spectrum Collaborations
B. Careful Selection of Region
C. Establishing Credentials - Indicators of Reputability
(Accreditation, Licensure, Transplant Track Records)
D. Merger and Acquisition Potential
E. Multi-National Marketing Framework
F. Parental Referral Programs
G. Effective Communication of Cord Blood Banking Services
H. Rapid Integration of New Technologies
I. Low-Cost Operating Environment
J. Government Support and Affiliation
K. Utilizing Third-Party Cryogenic Storage Facilities
L. Capital Resources
IX. Comparing to the Competition – Setting Yourself Apart
A. Ten Largest U.S. Cord Blood Banks – Pricing and Characteristics Comparison
B. Cost Variation
C. Accreditation Standards for U.S. Cord Blood Banks
D. Technical Variables
1. Vapor-Phase Storage vs. Liquid-Phase Storage
2. Cryo-bags vs. Cryo-vials
3. Pentastarch vs. Hetastarch
4. Computer Controlled vs. Manual Rate Freezing
5. Whole Sample vs. Volume Reduction
E. Corporate Variables
1. Corporate Stability
2. Scientific Expertise
PART 3: Parent Survey - Continuing to Grow by Listening to Expectant Parents
I. Expectant Parent Survey
A. Characteristics of Survey Respondent Population
B. Survey Results - Respondents Who Banked Cord Blood Privately
C. Survey Results - Respondents Who Banked Cord Blood Publicly
D. Survey Results - Respondents Who Did Not Bank Cord Blood
E. Survey Results - All Respondents
II. Summary of Conclusions
Appendix A – Existing Conditions Treatable with Cord Blood Transplant
Appendix B – Global List of Cord Blood Banks
Appendix C – AABB Accredited Cord Blood Banks Worldwide
Appendix D – Accreditation Standards by U.S Cord Blood Bank, Public and Private
Appendix E – Cord Blood Stem Cell Legislation by U.S. State